Global Medical REIT Inc. (NYSE:GMRE - Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 1,800,000 shares, an increase of 30.4% from the March 15th total of 1,380,000 shares. Approximately 2.9% of the shares of the company are short sold. Based on an average daily trading volume, of 542,500 shares, the short-interest ratio is presently 3.3 days.
Wall Street Analysts Forecast Growth
Separately, B. Riley initiated coverage on Global Medical REIT in a report on Thursday, April 3rd. They set a "neutral" rating and a $9.00 target price for the company.
Check Out Our Latest Stock Report on GMRE
Global Medical REIT Stock Performance
Shares of Global Medical REIT stock traded up $0.01 during trading on Thursday, hitting $7.67. 35,963 shares of the stock were exchanged, compared to its average volume of 536,847. The company has a debt-to-equity ratio of 1.26, a quick ratio of 0.28 and a current ratio of 0.28. Global Medical REIT has a 12 month low of $6.75 and a 12 month high of $10.46. The stock's fifty day moving average is $8.22 and its 200 day moving average is $8.38. The stock has a market cap of $512.90 million, a PE ratio of -383.56, a P/E/G ratio of 1.43 and a beta of 1.12.
Global Medical REIT (NYSE:GMRE - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.01 by $0.21. The company had revenue of $35.16 million for the quarter, compared to analyst estimates of $34.87 million. Global Medical REIT had a net margin of 3.23% and a return on equity of 0.86%. As a group, sell-side analysts anticipate that Global Medical REIT will post 0.81 EPS for the current year.
Global Medical REIT Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Wednesday, April 9th. Shareholders of record on Friday, March 21st were given a dividend of $0.21 per share. The ex-dividend date of this dividend was Friday, March 21st. This represents a $0.84 dividend on an annualized basis and a yield of 10.95%. Global Medical REIT's dividend payout ratio (DPR) is presently 8,400.00%.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the stock. State Street Corp boosted its stake in Global Medical REIT by 1.5% during the 3rd quarter. State Street Corp now owns 1,924,433 shares of the company's stock valued at $19,468,000 after purchasing an additional 28,444 shares in the last quarter. Geode Capital Management LLC boosted its stake in Global Medical REIT by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 1,647,979 shares of the company's stock valued at $12,724,000 after buying an additional 25,820 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Global Medical REIT by 11.4% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 1,260,098 shares of the company's stock worth $9,728,000 after acquiring an additional 128,449 shares during the period. Charles Schwab Investment Management Inc. raised its position in Global Medical REIT by 2.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 877,096 shares of the company's stock worth $6,771,000 after acquiring an additional 23,993 shares in the last quarter. Finally, Pacific Ridge Capital Partners LLC raised its position in Global Medical REIT by 31.9% in the fourth quarter. Pacific Ridge Capital Partners LLC now owns 712,101 shares of the company's stock worth $5,497,000 after acquiring an additional 172,171 shares in the last quarter. Institutional investors and hedge funds own 57.52% of the company's stock.
Global Medical REIT Company Profile
(
Get Free Report)
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Featured Articles
Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.